124-Iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancer

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 10, 2007, Pages 690-693

  Freudenberg, L S ^a   Jentzen, W ^a   Marlowe, R J ^b   Koska, W W ^a   Luster, M ^a   Bockisch, A ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b University of Würzburg ^*

Author keywords

124 iodine positron emission tomography computed tomography dosimetry; Adolescents; Children; Differentiated thyroid carcinoma; Pediatric patients; Radioiodine treatment; Recombinant human thyroid stimulating hormone; Thyroid hormone withdrawal

Indexed keywords

IODINE 124; IODINE 131;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DOSIMETRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; THYROID CANCER;

ADOLESCENT; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 36849021652     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985360     Document Type: Article

References (19)

1. Benua RS, Cicale NR, Sonenberg M, Rawson RW. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med 1962; 87: 171-182
2. Eschmann SM, Reischl G, Bilger K, Kupferschlager J, Thelen MH, Dohmen BM, Besenfelder H, Bares R. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eur J Nucl Med Mol Imaging 2002; 29: 760-767
3. Faggiano A, Coulot J, Bellon L, Talbot M, Caillou B, Ricard M, Bidart JM, Schlumberger M. Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue. J Clin Endocrinol Metab 2004; 89: 4264-4266
4. Farahati J, Bucsky P, Parlowsky T, Mader U, Reiners C. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer 1997; 80: 2156-2162
5. Fleming ID CJ, Henson DE (eds). AJCC Cancer Staging Manual 5th ed. Lippincott-Raven, Philadelphia, PA, 1997
6. Freudenberg LS, Antoch G, Jentzen W, Pink R, Knust J, Görges R, Müller SP, Bockisch A, Debatin JF, Brandau W. Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol 2004;14: 2092-2098
7. nd edition. Springer, Berlin, 2005
8. Freudenberg L, Jentzen W, Goerges R, Petrich T, Marlowe RJ, Knust J, Bockisch A. 124I-PET dosimetry in advanced differentiated thyroid cancer. Therapeutic impact. Nuklearmedizin 2007, in press
9. Freudenberg LS, Jentzen W, Müller SP, Bockisch A. Detection feasibility study of disseminated lung metastases using iodine-124 PET in differentiated thyroid cancer [abstract]. Nuklearmedizin 2007; 46: A9-A10
10. Furhang EE, Larson SM, Buranapong P, Humm JL. Thyroid cancer dosimetry using clearance fitting. J Nucl Med 1999; 40: 131-136
11. Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer 2005; 12: 773-803
12. Jentzen W, Freudenberg LS, Eising EG, Heinze M, Brandau W, Bockisch A. Segmentation of PET volumes by iterative image thresholding. J Nucl Med 2007; 48: 108-114
13. Jentzen W, Freudenberg LS, Eising EG, Brandau W, Bockisch A. Analyse der Jod-124-Zeitsaktivitaetskurven bei der Läsionsdosimetrie beim differenzierten Schildrüsenkarzinom: Das 3-Tage-Protokol ist ausreichend [abstract]. Nuklearmedizin 2006; 45: A28
14. Knust EJ, Dutschka K, Weinreich R. Preparation of 1241 solutions after thermodistillation of irradiated 124TeO2 targets. Appl Radiat Isot 2000; 52: 181-184
15. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculations. Society of Nuclear Medicine, New York, 1991
16. Pentlow KS, Graham MC, Lambrecht RM, Daghighian F, Bacharach SL, Bendriem B, Finn RD, Jordan K, Kalaigian H, Karp JS, Robeson WR, Larson SM. Quantitative imaging of iodine-124 with PET. J Nucl Med 1996; 37: 1557-1562
17. Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A, Robbins RJ, Larson SM. Patient-specific dosimetry for 1311 thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 2004; 45: 1366-1372
18. Snyder WS, Ford MR, Warner GG, Watson SB. "S," absorbed dose per unit cumulated activity for selected radionuclides and organs. Society of Nuclear Medicine, New York, NY, 1975
19. Zimmerman D, Hay ID, Gough IR, Goellner JR, Ryan JJ, Grant CS, MacConahey WM. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 1988; 104: 1157-1166